News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Omega Fund IV, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Omega Fund IV, L.P. reports a 10.6% stake in Replimune Group, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G/A
| Omega Fund IV, L.P. reports a 16.5% stake in Replimune Group, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Omega Fund IV, L.P. reports a 4% stake in Translate Bio, Inc. |
| 02/13/2019 |
SC 13G
| Omega Fund IV, L.P. reports a 5.4% stake in § 240.13d-2 Translate Bio, Inc. |
| 02/13/2019 |
SC 13D
| Omega Fund IV, L.P. reports a 17.2% stake in ESSA Pharma Inc. |
| 02/13/2019 |
SC 13G
| Omega Fund IV, L.P. reports a 16.2% stake in § 240.13d-2 Replimune Group, Inc. |
| 02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|